Pulmonology clinical trials recruiting in Texas

82 recruiting pulmonology trials match in Texas. Showing 20.

• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)Recruiting

  Phase 3 · Generate Biomedicines · San Antonio, Texas

• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseRecruiting

  Phase 2 · AstraZeneca · Boerne, Texas

• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)Recruiting

  Phase 3 · GlaxoSmithKline · Corsicana, Texas

• Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)Recruiting

  N/A · Boston Children's Hospital · Dallas, Texas

• Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer ScreeningRecruiting

  N/A · Freenome Holdings Inc. · Houston, Texas

• Depemokimab Asthma Imaging and Bronchoscopy Sub-StudyRecruiting

  Phase 3 · GlaxoSmithKline · Brooksville, Florida

• myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the HomeRecruiting

  N/A · Temple University · Houston, Texas

• Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)Recruiting

  Phase 2 · Cumberland Pharmaceuticals · Dallas, Texas

• Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisRecruiting

  Phase 2 · InSilico Medicine Hong Kong Limited · Dallas, Texas

• STRIVE Post-Market Registry StudyRecruiting

  N/A · Olympus Corporation of the Americas · Dallas, Texas

• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)Recruiting

  Phase 3 · AstraZeneca · Boerne, Texas

• Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPDRecruiting

  Phase 2 · Johns Hopkins University · Baltimore, Maryland

• A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)Recruiting

  Phase 2 · Deciphera Pharmaceuticals, LLC · Austin, Texas

• A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaRecruiting

  Phase 3 · GlaxoSmithKline · Dallas, Texas

• A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic BronchitisRecruiting

  Phase 2 · UCB Biopharma SRL · Boerne, Texas

• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting

  N/A · Duke University · Austin, Texas

• A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With AsthmaRecruiting

  Phase 2 · AstraZeneca · Lewisville, Texas

• Phase 2 Study to Assess the Safety and Efficacy of ANG003Recruiting

  Phase 2 · Anagram Therapeutics, Inc. · Dallas, Texas

• Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentRecruiting

  Phase 3 · AstraZeneca · McKinney, Texas

• Health Outcomes of Parents With Cystic Fibrosis-Aim 2Recruiting

  N/A · University of Pittsburgh · Dallas, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.